Hussman Strategic Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,000
| Closed | -$866K | – | 297 |
|
|
2023
Q3 | $866K | Buy |
+21,000
| New | +$866K | 0.17% | 215 |
|
|
2022
Q2 | – | Sell |
-3,100
| Closed | -$236K | – | 361 |
|
|
2022
Q1 | $236K | Hold |
3,100
| – | – | 0.05% | 287 |
|
|
2021
Q4 | $462K | Hold |
3,100
| – | – | 0.1% | 254 |
|
|
2021
Q3 | $451K | Hold |
3,100
| – | – | 0.1% | 247 |
|
|
2021
Q2 | $607K | Buy |
+3,100
| New | +$607K | 0.13% | 243 |
|
|
2020
Q3 | – | Sell |
-20,600
| Closed | -$1.84M | – | 311 |
|
|
2020
Q2 | $1.84M | Sell |
20,600
-10,150
| -33% | -$907K | 0.47% | 86 |
|
|
2020
Q1 | $1.92M | Sell |
30,750
-10,500
| -25% | -$654K | 0.52% | 62 |
|
|
2019
Q4 | $3.15M | Sell |
41,250
-10,250
| -20% | -$781K | 1% | 22 |
|
|
2019
Q3 | $2.6M | Buy |
+51,500
| New | +$2.6M | 0.74% | 45 |
|